UPDATE 2-Maryland charges Insys with engaging in deceptive opioid scheme
September 06, 2018 at 13:53 PM EDT
Maryland on Thursday charged Insys Therapeutics Inc with deceptively marketing a powerful opioid pain killer so that it was prescribed inappropriately beyond its intended use with cancer patients.
